Pre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Abstract

pharyngeal swab was positive for 2019-nCoV nucleic acid 2 days after hospitalization.After the patient received 7 days of treatment, combined with interferon inhalation, real-time fluorescence polymerase chain reaction of the patient's pharyngeal swab became negative for 2019-nCoV nucleic acid. At 7 days, chest CT showed decreasing ground-glass opacities (Figure b). At day 13 after admission, the ground-glass opacities in the right lung had resolved; the left ground-glass opacities showed partial resolution (Figure c). CT scans (slice thickness = 1 mm) in a 46-year-old woman with the 2019 novel coronavirus (2019-nCoV). (a) Transverse thin-section CT scan obtained at first day after admission shows multiple ground-glass opacities in both lungs. Ground-glass opacities are seen in the superior segment of both lower lobes. (b) Follow-up CT scan obtained on day 7 after admission shows ground-glass opacities are completely resolved in the superior segment of right lower lobe and partly resolved in the superior segment of left lower lobe. (c) Follow-up CT scan obtained at day 13 after admission shows ground-glass opacities are completely resolved in the superior segment of right lower lobe and partly resolved in the superior segment of left lower lobe.A 46-year-old woman presented to the hospital with a 7-day history of fever without chills and rigor, nasal discharge, cough, and myalgia. She had stayed with a friend who had been diagnosed with 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan, China, 5 days previously.At presentation, her body temperature was elevated to 38.3°C (100.9°F) with normal pulmonary auscultation. Laboratory studies showed a normal total white blood cell count of 4.2 3 10 9 /L (normal range, 4.0-10.0 3 10 9 /L), and the differential count showed 52.9% neutrophils (normal range, 40.0%-74.0%) and 28.3% lymphocytes (normal range, 18.0%-43.0%). There were elevated blood levels for C-reactive protein (6.4 mg/L; normal range, 0-6 mg/L), erythrocyte sedimentation rate (27 mm/h; normal range, 0-20 mm/h), and D-dimer (566 ng/mL; normal range, 500 ng/mL).Unenhanced chest CT showed multiple bilateral and peripheral ground-glass opacities (Figure a) in the superior segments of both lower lobes without sparing of subpleural regions (1,2). Real-time fluorescence polymerase chain reaction of the patient's This copy is for personal use only. To order printed copies, contact reprints@rsna.org

Clinical characterization and chest CT findings in laboratory-confirmed COVID-19: a systematic review and meta-analysis

“…Also, bilateral multilobe involvement was dominant in stages 2, 3 and 4. Similar to some case reports (23,24), it can be concluded that chest CT (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.…”

Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area

“…The latency period of this disease is 1e14 days, mostly 3e7 days. 3,4 The clinical manifestations are mainly fever and fatigue, but some patients may also be asymptomatic virus carriers, with mild-onset symptoms and no fever.…”

“…They are mainly distributed underneath the pleura with uneven density. These CT manifestations reflect the pathological process of lung injury in patients with viral pneumonia 3,4 and the distribution of most of the lesions are in the peripheral zone of the lungs, peripheral bronchus, and alveoli. This distribution may be related to the infection mode of viral pneumoniadrespiratory droplet transmission.…”

Coronavirus Disease 2019 (COVID-19): A Perspective from China

“…The study by Song et al (42) concluded that greater consolidation indicated disease progression. Some case reports showed that smaller size, extent, and absorption of these lesions indicate the improvement (32,42,(51)(52)(53). Tables Table 1: The suspected case with typical imaging findings of pneumonia (only for Hubei)…”